CUL4A
CUL4A[edit | edit source]
CUL4A is a gene that encodes a protein known as Cullin-4A, which is a member of the cullin family of proteins. These proteins are involved in the ubiquitin-proteasome system, a critical pathway for protein degradation and regulation within the cell. CUL4A plays a significant role in various cellular processes, including DNA repair, cell cycle regulation, and transcriptional control.
Structure[edit | edit source]
CUL4A is part of the cullin-RING ubiquitin ligase (CRL) complex, which is responsible for targeting specific proteins for ubiquitination and subsequent degradation by the proteasome. The CUL4A protein serves as a scaffold within this complex, facilitating the assembly of other components, including the RING-box protein and substrate receptors.
Function[edit | edit source]
The primary function of CUL4A is to mediate the ubiquitination of target proteins, marking them for degradation. This process is essential for maintaining cellular homeostasis and regulating various biological pathways. CUL4A is particularly important in:
- DNA Repair: CUL4A is involved in the nucleotide excision repair (NER) pathway, which repairs DNA damage caused by ultraviolet (UV) light and other mutagens.
- Cell Cycle Regulation: By targeting specific cell cycle regulators for degradation, CUL4A helps control the progression of the cell cycle.
- Transcriptional Regulation: CUL4A can influence gene expression by modulating the stability of transcription factors and other regulatory proteins.
Clinical Significance[edit | edit source]
Alterations in the CUL4A gene have been associated with various cancers, including breast cancer, lung cancer, and melanoma. Overexpression of CUL4A can lead to increased degradation of tumor suppressor proteins, contributing to tumorigenesis. As a result, CUL4A is considered a potential target for cancer therapy.
Research and Therapeutic Implications[edit | edit source]
Research into CUL4A and its associated pathways is ongoing, with the aim of developing targeted therapies that can modulate its activity. Inhibitors of the CUL4A complex are being explored as potential treatments for cancers where CUL4A is dysregulated.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
